Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Proudman

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Arthritis Research & Therapy|June 25, 2024
The impact of gastroesophageal reflux disease and its treatment on interstitial lung disease outcomesA Quinlivan, D Neuen, D Hansen, et al.
Internal Medicine Journal|September 5, 2015
Cost savings with a new screening algorithm for pulmonary arterial hypertension in systemic sclerosisA Quinlivan, V Thakkar, W Stevens, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 7, 2015
Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components AnalysisK A Patterson, P J Roberts-Thomson, S Lester, et al.
Clinical and Experimental Rheumatology|February 26, 2014
The association of antiphospholipid antibodies with cardiopulmonary manifestations of systemic sclerosisK B Morrisroe, W Stevens, H Nandurkar, et al.
Arthritis and Rheumatism|August 16, 2000
Treatment of poor-prognosis early rheumatoid arthritis. A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine aloneS M Proudman, P G Conaghan, C Richardson, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Arthritis Research & Therapy|June 25, 2024
The impact of gastroesophageal reflux disease and its treatment on interstitial lung disease outcomesA Quinlivan, D Neuen, D Hansen, et al.
Internal Medicine Journal|September 5, 2015
Cost savings with a new screening algorithm for pulmonary arterial hypertension in systemic sclerosisA Quinlivan, V Thakkar, W Stevens, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 7, 2015
Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components AnalysisK A Patterson, P J Roberts-Thomson, S Lester, et al.
Clinical and Experimental Rheumatology|February 26, 2014
The association of antiphospholipid antibodies with cardiopulmonary manifestations of systemic sclerosisK B Morrisroe, W Stevens, H Nandurkar, et al.
Arthritis and Rheumatism|August 16, 2000
Treatment of poor-prognosis early rheumatoid arthritis. A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine aloneS M Proudman, P G Conaghan, C Richardson, et al.
Pageof 3